Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation.

Source:http://linkedlifedata.com/resource/pubmed/id/21828004

Proc. Natl. Acad. Sci. U.S.A. 2011 Aug 9 108 32 13287-92

Download in:

View as

Triples

General Info

PMID
21828004